Africa Asia Middle East عربي Français Português free subscription RSS IRIN Site Map
Global HIV/AIDS news and analysis
Advanced search
 Sunday 07 February 2010
Weekly reports 
In-Depth reports 
Country profiles 
Fact files 
Most read 
Print report Bookmark and Share
GLOBAL: Breakthrough could create better ARVs

Photo: Gary Hampton/World Lung Foundation
The puzzle has been solved
NAIROBI, 1 February 2010 (PlusNews) - Scientists have finally discovered the structure of a key enzyme found in HIV and similar viruses, a breakthrough that has crucial implications for HIV treatment.

Researchers from Imperial College London, in the UK, and Harvard University, in the US, developed a crystal that could reveal the structure of integrase - an enzyme used by HIV to integrate its genetic material into a host cell.

Many researchers had tried and failed to unravel the three-dimensional structure of integrase, which is bound to viral DNA. When someone is infected with HIV, the virus uses integrase to paste a copy of its genetic information into the person's DNA.

The new study, published in the latest edition of Nature, a scientific journal, revealed how a class of life-prolonging antiretroviral drugs - integrase inhibitors - functions. The drugs work by blocking integrase, but for a long time scientists did not understand fully how the medicines managed to do this, or how to improve them.

"We now know how drugs that target integrase - such as Isentress [an integrase inhibitor produced by pharmaceutical company Merck & Co] - bind to and block integrase, meaning it is now possible to improve the drugs on the market," Dr Peter Cherepanov, of Imperial College London, one of the study's lead authors, told IRIN/PlusNews.

''This is the holy grail of HIV research ... it opens a whole new door for manufacturers of HIV medication''
"Now we have this information, drug developers can modify the available drugs to work better - for instance, to bind tighter to integrase," he said. "We will also be able to better understand and explain HIV drug resistance, since we now know how these HIV drugs work."

Using a version of integrase borrowed from a retrovirus similar to HIV, the researchers were able to grow a crystal after more than 40,000 unsuccessful attempts.

"This is the holy grail of HIV research," said Dr Matilu Mwau, a virus researcher at the Kenya Medical Research Institute. "It has the potential to increase the repertoire of drugs to treat HIV; it opens a whole new door for manufacturers of HIV medication."

"In the developing world we do not tailor-make drug combinations for HIV patients - we treat HIV from a public health perspective, where most people are put on a similar combination," he said. "More drugs available mean better chances for people to be put on second- and third-line treatment regimens where first-line drugs don't work."


Theme(s): (PLUSNEWS) Care/Treatment - PlusNews, (PLUSNEWS) HIV/AIDS (PlusNews)


[This report does not necessarily reflect the views of the United Nations]
Print report Bookmark and Share
FREE Subscriptions
Your e-mail address:

Submit your request
 More on Afghanistan
GLOBAL: UNITAID greenlights patent pool for AIDS drugs
GLOBAL: Microbicide hopes dashed again
GLOBAL: UNAIDS partners with religious groups to achieve universal access
GLOBAL: Integrated health systems "boost the fight against HIV"
GLOBAL: PEPFAR unveils new strategy but more funds needed
 More on Care/Treatment - PlusNews
SUDAN: Positive networks fight HIV in the south
SOUTH AFRICA: Military gets new HIV policy
ZIMBABWE: Gov't to double number of people on HIV treatment
KENYA: Special tribunal for HIV-related issues
ZIMBABWE: Raising more money for HIV/AIDS
 Most Read 
SUDAN: Universal access still a long way off in the south
ZIMBABWE: HIV-positive people want constitutional rights
SUDAN: Positive networks fight HIV in the south
GLOBAL: IRIN/PlusNews Weekly Issue 471, 5 February 2010
Back | Home page

Services:  Africa | Asia | Middle East | Film & TV | Photo | Radio | Live news map | E-mail subscription
Feedback · IRIN Terms & Conditions · Really Simple Syndication News Feeds · About PlusNews · Jobs · Donors

Copyright © IRIN 2010
This material comes to you via IRIN, the humanitarian news and analysis service of the UN Office for the Coordination of Humanitarian Affairs. The opinions expressed do not necessarily reflect those of the United Nations or its Member States. Republication is subject to terms and conditions as set out in the IRIN copyright page.